Aids in the investigation of virilizing endocrinopathies and in managing congenital adrenal hyperplasia in conjunction with other sex steroids. Not recommended for initial evaluation of polycystic ovarian syndrome.
Quantitative High Performance Liquid Chromatography-Tandem Mass Spectrometry
New York DOH Approval Status
Specimen should be collected between 6-10 a.m.
Serum separator tube or green (sodium or lithium heparin).
Transfer 1 mL serum or plasma to an ARUP Standard Transport Tube. (Min: 0.3 mL) Also acceptable: EDTA plasma.
After separation from cells: Ambient: 24 hours; Refrigerated: 1 week; Frozen: 6 months
Effective August 19, 2013
|Premature Infants, 26-28 weeks-Day 4||0.92-2.82 ng/mL||0.92-2.82 ng/mL|
|Premature Infants, 31-35 weeks-Day 4||0.80-4.46 ng/mL||0.80-4.46 ng/mL|
|Full-term Infants, 1-7 days||0.20-2.90 ng/mL||0.20-2.90 ng/mL|
|8-30 days||0.18-0.80 ng/mL||0.18-0.80 ng/mL|
|1-5 months||0.06-0.68 ng/mL||0.06-0.68 ng/mL|
|6-24 months||Less than 0.15 ng/mL||0.03-0.15 ng/mL|
|2-3 years||Less than 0.16 ng/mL||Less than 0.11 ng/mL|
|4-5 years||0.02-0.21 ng/mL||0.02-0.17 ng/mL|
|6-7 years||0.02-0.28 ng/mL||0.01-0.29 ng/mL|
|8-9 years||0.04-0.42 ng/mL||0.03-0.30 ng/mL|
|10-11 years||0.09-1.23 ng/mL||0.07-0.39 ng/mL|
|12-13 years||0.24-1.73 ng/mL||0.10-0.64 ng/mL|
|14-15 years||0.39-2.00 ng/mL||0.18-0.94 ng/mL|
|16-17 years||0.35-2.12 ng/mL||0.30-1.13 ng/mL|
|18-39 years||0.26-2.14 ng/mL||0.33-1.34 ng/mL|
|40 years and older||0.13-0.82 ng/mL||0.23-0.89 ng/mL|
|Pre-menopausal||0.26-2.14 ng/mL||Does Not Apply|
|Postmenopausal||0.13-0.82 ng/mL||Does Not Apply|
|Tanner Stage I||0.05-0.51 ng/mL||0.04-0.32 ng/mL|
|Tanner Stage II||0.15-1.37 ng/mL||0.08-0.48 ng/mL|
|Tanner Stage III||0.37-2.24 ng/mL||0.14-0.87 ng/mL|
|Tanner Stage IV-V||0.35-2.05 ng/mL||0.27-1.07 ng/mL|
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
Laboratory Developed Test (LDT)
|Component Test Code*||Component Chart Name||LOINC|
|2001639||Androstenedione by TMS||1854-9|